ono-5788
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 7, 2018 (NCT03571594)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
SULT2B1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03849872 | Phase 1 | Feb 27, 2019 | Ono Pharmaceuticals, Pharmaceutical Research Associates, Inc. (PRA) |
| NCT03571594 | Phase 1 | Jun 7, 2018 | Celerion, Ono Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ono Pharmaceuticals | For profit | 2 | 2 | 1 | 2018 |
| Celerion | For profit | 1 | 0 | 1 | 2018 |
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1